Literature DB >> 15501751

Recognition of mycobacterial antigens delivered by genetically detoxified Bordetella pertussis adenylate cyclase by T cells from cattle with bovine tuberculosis.

H Martin Vordermeier1, Marcela Simsova, Katalin A Wilkinson, Robert J Wilkinson, R Glyn Hewinson, Peter Sebo, Claude Leclerc.   

Abstract

The exponential increase in the incidence of tuberculosis in cattle over the last two decades in the British national herd constitutes a significant economic problem. Therefore, research efforts are under way to develop cattle tuberculosis vaccines and specific diagnostic reagents to allow the distinction of vaccinated from infected animals. Mycobacterial antigens like ESAT-6 and CFP10 allow this distinction. This study investigates whether fusion protein of ESAT-6 or CFP10 with genetically detoxified Bordetella pertussis adenylate cyclase (CyaA) are recognized by Mycobacterium bovis-infected cattle more effectively than conventional recombinant proteins are, thus enhancing sensitivity or reducing the amount of antigens required. By measuring the frequencies of gamma interferon (IFN-gamma)-producing cells, we were able to show that the presentation of CFP10 as a CyaA fusion protein enhanced the molecular efficiency of its recognition 20-fold, while the recognition of ESAT-6 was not improved by CyaA delivery. Furthermore, in the whole-blood IFN-gamma test currently used in the field, the delivery of CFP10 and ESAT-6 by fusion to CyaA increased the amount of IFN-gamma produced and hence the proportion of infected animals responding to CFP10. The improved T-cell recognition of CyaA336/CFP10 was found to be dependent upon interaction with CD11b. In addition, presentation of CyaA336/CFP10 to CD4+ T cells was chloroquine sensitive, and CFP10 delivery by CyaA resulted in its accelerated presentation to T cells. In conclusion, the use of CyaA fusion proteins with ESAT-6 and CFP10 has the potential to improve the sensitivity of immunodiagnostic tests detecting bovine tuberculosis in cattle.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501751      PMCID: PMC523049          DOI: 10.1128/IAI.72.11.6255-6261.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis.

Authors:  G Dadaglio; Z Moukrim; R Lo-Man; V Sheshko; P Sebo; C Leclerc
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying multiple copies of a viral CD8(+) T-cell epitope.

Authors:  P Sebo; Z Moukrim; M Kalhous; N Schaft; G Dadaglio; V Sheshko; C Fayolle; C Leclerc
Journal:  FEMS Immunol Med Microbiol       Date:  1999-11

3.  Bordetella pertussis adenylate cyclase toxin: a vehicle to deliver CD8-positive T-cell epitopes into antigen-presenting cells.

Authors:  P Guermonprez; C Fayolle; G Karimova; A Ullmann; C Leclerc; D Ladant
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

4.  Delivery of a MalE CD4(+)-T-cell epitope into the major histocompatibility complex class II antigen presentation pathway by Bordetella pertussis adenylate cyclase.

Authors:  Jiina Loucká; Géraldine Schlecht; Jana Vodolánová; Claude Leclerc; Peter Sebo
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

5.  Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity.

Authors:  C Fayolle; A Osickova; R Osicka; T Henry; M J Rojas; M F Saron; P Sebo; C Leclerc
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle.

Authors:  H M Vordermeier; A Whelan; P J Cockle; L Farrant; N Palmer; R G Hewinson
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

7.  Effective DNA vaccination of cattle with the mycobacterial antigens MPB83 and MPB70 does not compromise the specificity of the comparative intradermal tuberculin skin test.

Authors:  H M Vordermeier; P J Cockle; A O Whelan; S Rhodes; M A Chambers; D Clifford; K Huygen; R Tascon; D Lowrie; M J Colston; R G Hewinson
Journal:  Vaccine       Date:  2000-12-08       Impact factor: 3.641

8.  Assessment of defined antigens for the diagnosis of bovine tuberculosis in skin test-reactor cattle.

Authors:  J M Pollock; R M Girvin; K A Lightbody; R A Clements; S D Neill; B M Buddle; P Andersen
Journal:  Vet Rec       Date:  2000-06-03       Impact factor: 2.695

9.  Use of mycobacterial peptides and recombinant proteins for the diagnosis of bovine tuberculosis in skin test-positive cattle.

Authors:  B M Buddle; A R McCarthy; T J Ryan; J M Pollock; H M Vordermeier; R G Hewinson; P Andersen; G W de Lisle
Journal:  Vet Rec       Date:  2003-11-15       Impact factor: 2.695

10.  The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18).

Authors:  P Guermonprez; N Khelef; E Blouin; P Rieu; P Ricciardi-Castagnoli; N Guiso; D Ladant; C Leclerc
Journal:  J Exp Med       Date:  2001-05-07       Impact factor: 14.307

View more
  8 in total

1.  Structural basis for the interaction of Bordetella pertussis adenylyl cyclase toxin with calmodulin.

Authors:  Qing Guo; Yuequan Shen; Young-Sam Lee; Craig S Gibbs; Milan Mrksich; Wei-Jen Tang
Journal:  EMBO J       Date:  2005-09-01       Impact factor: 11.598

2.  ESAT-6 peptide recognition by bovine CD8+ lymphocytes of naturally infected cows in herds from southern Italy.

Authors:  Fabrizio Vitale; Stefano Reale; Enrico Petrotta; Santo Caracappa; Annalisa Barera; Marco Pio La Manna; Pasquale Macaluso; Nadia Caccamo; Francesco Dieli; Hans Martin Vordermeier; Guido Sireci; Alfredo Salerno
Journal:  Clin Vaccine Immunol       Date:  2006-04

3.  High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.

Authors:  Sandra Hervas-Stubbs; Laleh Majlessi; Marcela Simsova; Jana Morova; Marie-Jesus Rojas; Clémence Nouzé; Priscille Brodin; Peter Sebo; Claude Leclerc
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

4.  An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.

Authors:  Laleh Majlessi; Marcela Simsova; Zdenka Jarvis; Priscille Brodin; Marie-Jésus Rojas; Cécile Bauche; Clémence Nouzé; Daniel Ladant; Stewart T Cole; Peter Sebo; Claude Leclerc
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

5.  Efficient Ex vivo stimulation of Mycobacterium tuberculosis-specific T cells by genetically detoxified Bordetella pertussis adenylate cyclase antigen toxoids.

Authors:  Katalin A Wilkinson; Marcela Simsova; Elisabeth Schölvinck; Peter Sebo; Claude Leclerc; H Martin Vordermeier; Stuart J Dickson; Jillian R Brown; Robert N Davidson; Geoffrey Pasvol; Michael Levin; Robert J Wilkinson
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

Review 6.  Microbiota in viral infection and disease in humans and farm animals.

Authors:  Lijuan Yuan; Casey Hensley; Hassan M Mahsoub; Ashwin K Ramesh; Peng Zhou
Journal:  Prog Mol Biol Transl Sci       Date:  2020-04-24       Impact factor: 3.622

7.  Enhanced ex vivo stimulation of Mycobacterium tuberculosis-specific T cells in human immunodeficiency virus-infected persons via antigen delivery by the Bordetella pertussis adenylate cyclase vector.

Authors:  Tom G Connell; Muki S Shey; Ronnett Seldon; Molebogeng X Rangaka; Gilles van Cutsem; Marcela Simsova; Zuzana Marcekova; Peter Sebo; Nigel Curtis; Lavanya Diwakar; Graeme A Meintjes; Claude Leclerc; Robert J Wilkinson; Katalin A Wilkinson
Journal:  Clin Vaccine Immunol       Date:  2007-05-23

Review 8.  Bioengineering of Bordetella pertussis Adenylate Cyclase Toxin for Antigen-Delivery and Immunotherapy.

Authors:  Alexandre Chenal; Daniel Ladant
Journal:  Toxins (Basel)       Date:  2018-07-20       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.